Phatouros C C, Meyers P M, Dowd C F, Halbach V V, Malek A M, Higashida R T
Division of Interventional Neurovascular Radiology, University of California San Francisco Medical Center, San Francisco, California 94143-0628, USA.
Neurosurg Clin N Am. 2000 Jan;11(1):67-84, viii.
The treatment of carotid cavernous fistulas has undergone a fundamental transformation during the preceding 30 years. Endovascular techniques have not only largely replaced surgical management of this disease, but have also resulted in substantially lower rates of procedure-associated morbidity and mortality. Percutaneous transarterial occlusion of direct cavernous carotid fistulas with preservation of the carotid artery using detachable balloons is now considered the current preferred therapeutic objective. Concurrent progress in percutaneous transvenous embolization techniques and materials has led to more effective and better-tailored therapies for indirect (dural) carotid cavernous fistulas. The current understanding of the clinicopathologic mechanisms associated with carotid cavernous fistulas and the endovascular therapies used in the contemporary management of this condition are reviewed.
在过去30年里,颈动脉海绵窦瘘的治疗发生了根本性变革。血管内技术不仅在很大程度上取代了该疾病的外科治疗,而且还使手术相关的发病率和死亡率大幅降低。目前,使用可脱性球囊经皮经动脉闭塞直接海绵窦颈动脉瘘并保留颈动脉被认为是首选的治疗目标。经皮经静脉栓塞技术和材料的同步进展,为间接(硬脑膜)颈动脉海绵窦瘘带来了更有效、更具针对性的治疗方法。本文综述了目前对与颈动脉海绵窦瘘相关的临床病理机制以及当代治疗中所采用的血管内治疗方法的认识。